SOURCE: IO Circuit

August 17, 2007 06:30 ET

(OTC: VMCS) Targets 5% of the Oncology EMR Market

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO Circuit.

LAKE HARMONY, PA--(Marketwire - August 17, 2007) - VisualMED Clinical Solutions Corp. (OTCBB: VMCS) (FRANKFURT: VA6) announced that it has begun a comprehensive sales effort, targeting some of the United States' major cancer centers, with its flagship oncology module currently being implemented in Montreal, as recently reported.

To read the complete release, go to

Other active stocks are Compass Bancshares, Inc. (NASDAQ: CBSS), Applied Materials, Inc. (NASDAQ: AMAT) and UTStarcom, Inc. (NASDAQ: UTSI).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A Third Party has hired and paid $500.00 for the publication and circulation of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation do no trading of any kind and send No Faxes or emails.

Contact Information